ArticleCell reports. Medicine2024

Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer.

Michael J Campbell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.